170 related articles for article (PubMed ID: 31913151)
21. [A study of mixed phenotype acute leukemia based on the 2008 World Health Organization classification].
Park J; Chae H; Kim M; Lim J; Kim Y; Lee J; Chung NG; Cho B; Kim HK; Lee S; Han K
Korean J Lab Med; 2010 Dec; 30(6):525-32. PubMed ID: 21157134
[TBL] [Abstract][Full Text] [Related]
22. Acute leukemias of ambiguous origin.
Porwit A; Béné MC
Am J Clin Pathol; 2015 Sep; 144(3):361-76. PubMed ID: 26276768
[TBL] [Abstract][Full Text] [Related]
23. Multiparametric Flow Cytometry in Mixed Phenotype Acute Leukemia.
Koulmane Laxminarayana SL; Madireddy N; Manohar C; Udupa K
Indian J Hematol Blood Transfus; 2019 Jul; 35(3):451-458. PubMed ID: 31388256
[TBL] [Abstract][Full Text] [Related]
24. Successful acute lymphoblastic leukemia-type therapy in two children with mixed-phenotype acute leukemia.
Otsubo K; Yabe M; Yabe H; Fukumura A; Morimoto T; Kato M; Mochizuki H
Pediatr Int; 2016 Oct; 58(10):1072-1076. PubMed ID: 27577674
[TBL] [Abstract][Full Text] [Related]
25. First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.
Shiozawa Y; Fujita S; Nannya Y; Ogawa S; Nomura N; Kiguchi T; Sezaki N; Kudo H; Toyama T
Int J Hematol; 2024 Apr; 119(4):465-471. PubMed ID: 38424413
[TBL] [Abstract][Full Text] [Related]
26. Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia.
Horvat NP; Logothetis CN; Zhang L; Yun S; Sweet K
Cureus; 2022 Mar; 14(3):e23618. PubMed ID: 35505715
[TBL] [Abstract][Full Text] [Related]
27. How I treat mixed-phenotype acute leukemia.
Wolach O; Stone RM
Blood; 2015 Apr; 125(16):2477-85. PubMed ID: 25605373
[TBL] [Abstract][Full Text] [Related]
28. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.
Weinberg OK; Seetharam M; Ren L; Alizadeh A; Arber DA
Am J Clin Pathol; 2014 Dec; 142(6):803-8. PubMed ID: 25389334
[TBL] [Abstract][Full Text] [Related]
29. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
[TBL] [Abstract][Full Text] [Related]
30. Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia.
Pallavajjala A; Kim D; Li T; Ghiaur G; Jones RJ; Burns KH; Salzberg SL; Ning Y
Leuk Lymphoma; 2018 May; 59(5):1231-1238. PubMed ID: 28882084
[TBL] [Abstract][Full Text] [Related]
31.
Xiao W; Bharadwaj M; Levine M; Farnhoud N; Pastore F; Getta BM; Hultquist A; Famulare C; Medina JS; Patel MA; Gao Q; Lewis N; Pichardo J; Baik J; Shaffer B; Giralt S; Rampal R; Devlin S; Cimera R; Zhang Y; E Arcila M; Papaemmanuil E; Levine RL; Roshal M
Blood Adv; 2018 Dec; 2(23):3526-3539. PubMed ID: 30530780
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
[TBL] [Abstract][Full Text] [Related]
33. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
Roberts E; Oncale M; Safah H; Schmieg J
J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
[TBL] [Abstract][Full Text] [Related]
34. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
[TBL] [Abstract][Full Text] [Related]
35. Mixed-phenotypic acute leukemia series from tertiary care center.
Pawar RN; Banerjee S; Bramha S; Krishnan S; Bhattacharya A; Saha V; Chakrapani A; Bhave S; Chandy M; Nair R; Parihar M; Arora N; Mishra DK
Indian J Pathol Microbiol; 2017; 60(1):43-49. PubMed ID: 28195090
[TBL] [Abstract][Full Text] [Related]
36. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.
Montefiori LE; Mullighan CG
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701
[TBL] [Abstract][Full Text] [Related]
37. Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype.
Zheng R; Fuda F; Gagan JR; Weinberg OK; Koduru P; Cantu M; Ludwig K; Truscott JM; Collins R; Chung S; Madanat YF; Chen W
Leuk Res Rep; 2024; 21():100410. PubMed ID: 38273970
[TBL] [Abstract][Full Text] [Related]
38. Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used.
Pomerantz A; Rodriguez-Rodriguez S; Demichelis-Gomez R; Barrera-Lumbreras G; Barrales-Benitez O; Lopez-Karpovitch X; Aguayo-Gonzalez A
Blood Res; 2016 Dec; 51(4):233-241. PubMed ID: 28090485
[TBL] [Abstract][Full Text] [Related]
39. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis.
Maruffi M; Sposto R; Oberley MJ; Kysh L; Orgel E
Leukemia; 2018 Jul; 32(7):1515-1528. PubMed ID: 29550836
[TBL] [Abstract][Full Text] [Related]
40. Mixed phenotypic acute leukemia.
Krause JR; Findeis S
Proc (Bayl Univ Med Cent); 2018 Jan; 31(1):90-91. PubMed ID: 29686566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
